Compliance and Barriers in Hospital Price Transparency: A Cross-Sectional Evaluation of Alabama Hospitals With Emphasis on Spinal Surgery

医院价格透明度的合规性和障碍:以阿拉巴马州医院为例,重点关注脊柱外科手术的横断面评估

阅读:1

Abstract

OBJECTIVE:  Hospitals have been required to provide price transparency through various acceptable formats under federal regulatory guidance. Our objective was to assess levels of compliance among hospitals in Alabama, with an emphasis on centers performing spine surgery.  Methods: This cross-sectional policy evaluation utilized the Alabama Hospital Association (AHA) website to identify 124 hospitals in the state. Psychiatric and Veterans Affairs facilities were excluded, resulting in 106 hospitals for final analysis. Hospitals were dichotomized by pricing accessibility in accordance with the Centers for Medicare & Medicaid Services (CMS) guidelines. The presence of cash-discount pricing was assessed using each hospital's online pricing tool. RESULTS:  All hospitals (106/106) had a price transparency feature available. An online cost calculator was provided by 54.72% (58/106), while 44.34% (47/106) used a generic charge sheet or downloadable file. One hospital (0.94%) required a phone call to obtain pricing information. Personal information was required for access by 33.96% (36/106) of hospitals, whereas 20.75% (22/106) did not require personal information. Among hospitals requiring personal information, 19.44% (7/36) did not provide an available charge sheet. Among hospitals not requiring personal information, 81.82% (18/22) provided cash discount information, 45.45% (10/22) performed elective spinal surgery, and 54.55% (12/22) did not require personal information to obtain an insurance-based price estimate. CONCLUSIONS:  Most hospitals in Alabama are compliant with CMS price transparency requirements. However, substantial variation exists in the depth and accessibility of pricing information, with only a minority of hospitals meeting all CMS guideline elements. These inconsistencies represent ongoing barriers to effective price transparency and may limit the intended impact of CMS regulations on price sensitivity and competition within healthcare markets.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。